Dark Blue Therapeutics

Dark Blue Therapeutics is a biotechnology company that develops therapeutic solutions. Their platform utilizes scientific research to create treatments for various medical conditions.
    Size
    Small
    Phone
    +44 (0) 1865 803112
    Website
    darkbluetx.com
    Email
    Available in Endole App
    Locations
    Hayakawa Building, Littlemore, Edmund Halley Rd, OX4 4GB
    01865803112
    9:00 - 18:00
    Digital Popularity
    Social Media
    Company Details
    Dark Blue Therapeutics is operated by Dark Blue Therapeutics Ltd and is a Active company incorporated on 4 June 2020 with the registered office located in Oxford, Oxfordshire. Dark Blue Therapeutics Ltd was registered 5 years ago.
    Status
    Active
    Size
    Unreported
    Directors
    6
    Age
    5 years old
    Employees
    13
    Turnover
    Unreported
    Total Assets
    £12.31M
    Cash in Bank
    £11.66M
    Total Liabilities
    -£834K
    Dr Thomas Hanke
    Director • German • Lives in Germany • Born in Nov 1964
    Alastair Graham Mackinnon
    Director • British • Lives in England • Born in Nov 1970
    Dr Edwin Moses
    Director • British,belgian • Lives in Belgium • Born in Oct 1954
    Dr James Carmichael
    Director • British • Lives in UK • Born in Dec 1950
    Justian Craig Fox
    Director • British • Lives in England • Born in Nov 1975
    Ms Emma Smith
    Secretary
    More information on Dark Blue Therapeutics Ltd
    Teams
    All
    15
    Management
    7
    Research
    6
    Other
    3
    Alastair Mackinnon
    Chief Executive Officer
    Alastair Mackinnon
    Chief Executive Office Dark Blue Therapeutics • Joined Aug 2022
    John Pollard
    Chief Scientific Officer • Joined Jan 2022
    Alison Duester
    Finance Manager • Joined Feb 2023
    Lucy Coe
    Program Manager • Joined May 2022
    Craig Fox
    Board Director • Joined May 2024
    Nick Dixon-Clegg
    Board Director
    Alison Maloney
    Head Of Biology • Joined Sep 2022
    Sarah Major
    Director Of Medicinal Chemistry • Joined Jun 2023
    Iain Simpson
    Head Of Medicinal Chemistry - Dark Blue Therapeutics • Joined Feb 2022
    Alastair Mackinnon
    Chief Executive Officer
    John Pollard
    Chief Scientific Officer • Joined Jan 2022
    Alison Duester
    Finance Manager • Joined Feb 2023
    Lucy Coe
    Program Manager • Joined May 2022
    Craig Fox
    Board Director • Joined May 2024
    Nick Dixon-Clegg
    Board Director
    Sarah Major
    Director Of Medicinal Chemistry • Joined Jun 2023
    John Pollard
    Chief Scientific Officer • Joined Jan 2022
    Alison Maloney
    Head Of Biology • Joined Sep 2022
    Marta Llorca Cardeñosa
    Senior Research Scientist • Joined Apr 2023
    Gilbert Ansa
    Research Scientist • Joined Dec 2024
    Fenella Gross
    Research Scientist • Joined Apr 2023
    Camelia Mocanu
    Research Scientist • Joined Dec 2024
    Alastair Mackinnon
    Chief Executive Office Dark Blue Therapeutics • Joined Aug 2022
    Iain Simpson
    Head Of Medicinal Chemistry - Dark Blue Therapeutics • Joined Feb 2022
    Graham Craggs
    Director Of Translational And Mechanistic Biology • Joined Feb 2023
    View 15 members